Anthony Peter Weiss, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Schizophrenia | 22 | 2009 | 6972 | 0.930 |
Why?
|
| Schizophrenic Psychology | 11 | 2008 | 1648 | 0.880 |
Why?
|
| Verbal Learning | 5 | 2008 | 461 | 0.550 |
Why?
|
| Hippocampus | 11 | 2006 | 3775 | 0.550 |
Why?
|
| Mental Recall | 7 | 2008 | 1218 | 0.510 |
Why?
|
| Memory Disorders | 5 | 2008 | 1194 | 0.460 |
Why?
|
| Psychiatric Department, Hospital | 1 | 2013 | 134 | 0.410 |
Why?
|
| Medical Staff, Hospital | 2 | 2013 | 601 | 0.390 |
Why?
|
| Prefrontal Cortex | 4 | 2009 | 2224 | 0.310 |
Why?
|
| Mental Disorders | 6 | 2014 | 6853 | 0.280 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 4 | 2008 | 276 | 0.270 |
Why?
|
| Speech Acoustics | 1 | 2007 | 155 | 0.260 |
Why?
|
| Association Learning | 2 | 2007 | 219 | 0.260 |
Why?
|
| Dominance, Cerebral | 3 | 2005 | 616 | 0.250 |
Why?
|
| Magnetoencephalography | 1 | 2009 | 585 | 0.250 |
Why?
|
| Attention | 6 | 2008 | 2419 | 0.240 |
Why?
|
| Psychiatry | 3 | 2012 | 1714 | 0.230 |
Why?
|
| Length of Stay | 4 | 2012 | 6485 | 0.230 |
Why?
|
| Parietal Lobe | 1 | 2009 | 858 | 0.230 |
Why?
|
| Oxygen Consumption | 2 | 2008 | 1870 | 0.220 |
Why?
|
| Auditory Cortex | 1 | 2008 | 364 | 0.220 |
Why?
|
| Health Services | 1 | 2009 | 756 | 0.220 |
Why?
|
| Efficiency | 1 | 2007 | 480 | 0.220 |
Why?
|
| Auditory Perception | 1 | 2008 | 587 | 0.210 |
Why?
|
| Drug Therapy, Combination | 2 | 2011 | 6309 | 0.200 |
Why?
|
| Health Personnel | 1 | 2016 | 3390 | 0.200 |
Why?
|
| Speech Perception | 1 | 2007 | 512 | 0.200 |
Why?
|
| Antipsychotic Agents | 4 | 2011 | 3076 | 0.200 |
Why?
|
| Cognition Disorders | 5 | 2007 | 3967 | 0.200 |
Why?
|
| Magnetic Resonance Imaging | 14 | 2009 | 36532 | 0.200 |
Why?
|
| Medicare Part B | 1 | 2023 | 115 | 0.190 |
Why?
|
| Hemoglobins | 1 | 2008 | 1530 | 0.190 |
Why?
|
| Menthol | 1 | 2001 | 26 | 0.180 |
Why?
|
| Health Services Needs and Demand | 1 | 2009 | 1406 | 0.180 |
Why?
|
| Frontal Lobe | 2 | 2006 | 1410 | 0.180 |
Why?
|
| Pattern Recognition, Visual | 2 | 2005 | 820 | 0.180 |
Why?
|
| Nonprescription Drugs | 1 | 2001 | 119 | 0.170 |
Why?
|
| Computer Simulation | 1 | 2013 | 6255 | 0.170 |
Why?
|
| Hypericum | 1 | 1999 | 58 | 0.160 |
Why?
|
| Memory | 3 | 2009 | 2190 | 0.160 |
Why?
|
| Decision Making | 1 | 2013 | 3965 | 0.160 |
Why?
|
| Plants, Medicinal | 1 | 1999 | 166 | 0.160 |
Why?
|
| Attitude of Health Personnel | 2 | 2012 | 3925 | 0.160 |
Why?
|
| Emergency Service, Hospital | 3 | 2014 | 7875 | 0.150 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2001 | 366 | 0.140 |
Why?
|
| Cerebrovascular Circulation | 1 | 2008 | 2674 | 0.140 |
Why?
|
| Memory, Short-Term | 1 | 2004 | 1003 | 0.140 |
Why?
|
| Evidence-Based Medicine | 1 | 2009 | 3685 | 0.140 |
Why?
|
| Hallucinations | 1 | 1999 | 373 | 0.140 |
Why?
|
| Quality of Health Care | 2 | 2009 | 4300 | 0.130 |
Why?
|
| Catechol O-Methyltransferase | 2 | 2008 | 251 | 0.130 |
Why?
|
| Tomography, Emission-Computed | 4 | 2003 | 1006 | 0.130 |
Why?
|
| Electronic Health Records | 1 | 2012 | 4873 | 0.120 |
Why?
|
| Obsessive-Compulsive Disorder | 2 | 2002 | 1484 | 0.110 |
Why?
|
| Image Enhancement | 1 | 2004 | 2858 | 0.110 |
Why?
|
| Medical Audit | 2 | 2012 | 452 | 0.110 |
Why?
|
| Cognition | 4 | 2008 | 7049 | 0.110 |
Why?
|
| Polymorphism, Genetic | 3 | 2008 | 4247 | 0.100 |
Why?
|
| Adult | 30 | 2014 | 223044 | 0.100 |
Why?
|
| Nicotine | 2 | 2008 | 682 | 0.100 |
Why?
|
| Male | 36 | 2014 | 363698 | 0.100 |
Why?
|
| Neuropsychological Tests | 7 | 2008 | 7123 | 0.100 |
Why?
|
| Middle Aged | 27 | 2014 | 223009 | 0.100 |
Why?
|
| Humans | 47 | 2023 | 765968 | 0.100 |
Why?
|
| Emergency Services, Psychiatric | 1 | 2012 | 65 | 0.100 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2009 | 10383 | 0.100 |
Why?
|
| Risk Assessment | 1 | 2013 | 24282 | 0.100 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2006 | 8923 | 0.090 |
Why?
|
| Facial Expression | 2 | 2005 | 516 | 0.090 |
Why?
|
| Joint Commission on Accreditation of Healthcare Organizations | 1 | 2011 | 91 | 0.090 |
Why?
|
| Research Design | 1 | 2007 | 6209 | 0.090 |
Why?
|
| Crowding | 1 | 2012 | 142 | 0.090 |
Why?
|
| Alcoholism | 1 | 2001 | 1975 | 0.090 |
Why?
|
| Hospitals, Psychiatric | 1 | 2011 | 317 | 0.080 |
Why?
|
| Reality Testing | 1 | 2008 | 24 | 0.080 |
Why?
|
| Semantics | 2 | 2003 | 610 | 0.080 |
Why?
|
| Association | 1 | 2008 | 53 | 0.080 |
Why?
|
| Analysis of Variance | 5 | 2011 | 6203 | 0.080 |
Why?
|
| Parahippocampal Gyrus | 2 | 2005 | 117 | 0.070 |
Why?
|
| Reaction Time | 4 | 2008 | 2086 | 0.070 |
Why?
|
| Reference Values | 3 | 2005 | 4908 | 0.070 |
Why?
|
| Confidentiality | 1 | 2012 | 607 | 0.070 |
Why?
|
| Diabetes Mellitus | 1 | 2006 | 5891 | 0.070 |
Why?
|
| Radionuclide Imaging | 2 | 2002 | 1978 | 0.070 |
Why?
|
| Female | 27 | 2014 | 396112 | 0.070 |
Why?
|
| Time Factors | 7 | 2012 | 40065 | 0.070 |
Why?
|
| Gyrus Cinguli | 2 | 2004 | 1117 | 0.070 |
Why?
|
| Antidepressive Agents | 1 | 1999 | 2897 | 0.070 |
Why?
|
| Recruitment, Neurophysiological | 2 | 2004 | 35 | 0.070 |
Why?
|
| Cerebral Cortex | 2 | 2005 | 5767 | 0.070 |
Why?
|
| Efficiency, Organizational | 1 | 2012 | 697 | 0.070 |
Why?
|
| Photic Stimulation | 3 | 2009 | 1993 | 0.070 |
Why?
|
| Psychiatric Status Rating Scales | 6 | 2014 | 6014 | 0.070 |
Why?
|
| Habituation, Psychophysiologic | 2 | 2005 | 143 | 0.060 |
Why?
|
| Visual Perception | 2 | 2005 | 1394 | 0.060 |
Why?
|
| Behavioral Symptoms | 1 | 2007 | 187 | 0.060 |
Why?
|
| Nerve Net | 3 | 2009 | 2309 | 0.060 |
Why?
|
| Drug Utilization | 1 | 2011 | 1187 | 0.060 |
Why?
|
| Nicotinic Agonists | 1 | 2007 | 266 | 0.060 |
Why?
|
| Community Mental Health Services | 1 | 2008 | 381 | 0.060 |
Why?
|
| Treatment Failure | 1 | 2011 | 2652 | 0.060 |
Why?
|
| Brain Mapping | 4 | 2008 | 6601 | 0.060 |
Why?
|
| Patient Admission | 1 | 2012 | 1365 | 0.060 |
Why?
|
| Substance-Related Disorders | 1 | 2001 | 4416 | 0.060 |
Why?
|
| Mathematical Computing | 1 | 2004 | 143 | 0.060 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 3 | 2005 | 1989 | 0.060 |
Why?
|
| Awareness | 1 | 2008 | 653 | 0.060 |
Why?
|
| Temporal Lobe | 3 | 2005 | 1714 | 0.050 |
Why?
|
| Functional Laterality | 2 | 2008 | 2243 | 0.050 |
Why?
|
| Reading | 1 | 2007 | 539 | 0.050 |
Why?
|
| Acoustic Stimulation | 1 | 2008 | 1255 | 0.050 |
Why?
|
| Telencephalon | 1 | 2003 | 142 | 0.050 |
Why?
|
| Stereotaxic Techniques | 2 | 2003 | 551 | 0.050 |
Why?
|
| Outpatients | 1 | 2011 | 1595 | 0.050 |
Why?
|
| Word Association Tests | 1 | 2002 | 49 | 0.050 |
Why?
|
| Regression Analysis | 1 | 2012 | 6322 | 0.050 |
Why?
|
| Research Support as Topic | 1 | 2007 | 696 | 0.050 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2008 | 750 | 0.050 |
Why?
|
| Bipolar Disorder | 1 | 1999 | 5138 | 0.050 |
Why?
|
| Guidelines as Topic | 1 | 2009 | 1394 | 0.050 |
Why?
|
| Signal Detection, Psychological | 1 | 2002 | 83 | 0.050 |
Why?
|
| Psychosurgery | 1 | 2002 | 86 | 0.050 |
Why?
|
| Benchmarking | 1 | 2008 | 1052 | 0.050 |
Why?
|
| Goals | 1 | 2007 | 719 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2011 | 22223 | 0.050 |
Why?
|
| Internet | 1 | 2013 | 3106 | 0.050 |
Why?
|
| Chronic Disease | 2 | 2007 | 9347 | 0.040 |
Why?
|
| Insurance Coverage | 1 | 2012 | 1944 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2006 | 15652 | 0.040 |
Why?
|
| Lorazepam | 1 | 2001 | 155 | 0.040 |
Why?
|
| New England | 2 | 2014 | 1059 | 0.040 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2007 | 1737 | 0.040 |
Why?
|
| Mental Health | 1 | 2014 | 3278 | 0.040 |
Why?
|
| Limbic System | 1 | 2002 | 418 | 0.040 |
Why?
|
| Poisoning | 1 | 2001 | 254 | 0.040 |
Why?
|
| Fear | 2 | 2005 | 1499 | 0.040 |
Why?
|
| Regional Blood Flow | 1 | 2002 | 1478 | 0.040 |
Why?
|
| Administration, Topical | 1 | 2001 | 704 | 0.040 |
Why?
|
| Atrophy | 1 | 2004 | 1635 | 0.040 |
Why?
|
| Research | 1 | 2007 | 1975 | 0.040 |
Why?
|
| Oxygen | 2 | 2006 | 4241 | 0.040 |
Why?
|
| Amygdala | 1 | 2005 | 1377 | 0.040 |
Why?
|
| Fentanyl | 1 | 2001 | 457 | 0.040 |
Why?
|
| Brain | 2 | 2006 | 27171 | 0.040 |
Why?
|
| Brain Stem | 1 | 2002 | 853 | 0.030 |
Why?
|
| Lithium | 1 | 1999 | 597 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 2001 | 2229 | 0.030 |
Why?
|
| United States | 4 | 2023 | 72903 | 0.030 |
Why?
|
| Prospective Studies | 4 | 2014 | 54802 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2007 | 3139 | 0.030 |
Why?
|
| Administration, Cutaneous | 2 | 2008 | 715 | 0.030 |
Why?
|
| Age Factors | 1 | 2012 | 18380 | 0.030 |
Why?
|
| Ambulatory Care | 1 | 2006 | 2778 | 0.030 |
Why?
|
| Depressive Disorder, Major | 2 | 2003 | 4808 | 0.030 |
Why?
|
| Severity of Illness Index | 4 | 2007 | 15880 | 0.030 |
Why?
|
| Thalamus | 1 | 2001 | 1048 | 0.030 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 1999 | 1145 | 0.030 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2002 | 993 | 0.030 |
Why?
|
| Aged | 6 | 2023 | 171117 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2006 | 9649 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2011 | 7425 | 0.030 |
Why?
|
| Cerebellum | 1 | 2001 | 1518 | 0.030 |
Why?
|
| Emotions | 1 | 2005 | 2763 | 0.030 |
Why?
|
| Treatment Outcome | 5 | 2011 | 65188 | 0.030 |
Why?
|
| Genotype | 4 | 2008 | 13024 | 0.030 |
Why?
|
| Psychotic Disorders | 1 | 2008 | 3270 | 0.030 |
Why?
|
| Age of Onset | 1 | 2000 | 3344 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2008 | 4863 | 0.020 |
Why?
|
| Logistic Models | 1 | 2007 | 13266 | 0.020 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2014 | 394 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2007 | 18071 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2006 | 3529 | 0.020 |
Why?
|
| Hospital Departments | 1 | 2012 | 135 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2008 | 16047 | 0.020 |
Why?
|
| Comorbidity | 1 | 2006 | 10563 | 0.020 |
Why?
|
| Dopamine | 2 | 2008 | 1582 | 0.020 |
Why?
|
| Cross-Over Studies | 2 | 2008 | 2108 | 0.020 |
Why?
|
| Cohort Studies | 3 | 2012 | 41649 | 0.020 |
Why?
|
| Massachusetts | 2 | 2014 | 8875 | 0.020 |
Why?
|
| Delirium | 1 | 2001 | 1707 | 0.020 |
Why?
|
| Hospitals, Community | 1 | 2011 | 363 | 0.020 |
Why?
|
| Pteroylpolyglutamic Acids | 1 | 2007 | 9 | 0.020 |
Why?
|
| Psychomotor Performance | 2 | 2007 | 1881 | 0.020 |
Why?
|
| Valine | 1 | 2008 | 410 | 0.020 |
Why?
|
| Methionine | 1 | 2008 | 569 | 0.020 |
Why?
|
| Verbal Behavior | 1 | 2007 | 328 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2008 | 23601 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2006 | 26318 | 0.010 |
Why?
|
| Happiness | 1 | 2005 | 173 | 0.010 |
Why?
|
| Homocysteine | 1 | 2007 | 638 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2008 | 1740 | 0.010 |
Why?
|
| Double-Blind Method | 2 | 2008 | 12437 | 0.010 |
Why?
|
| Arousal | 1 | 2008 | 1171 | 0.010 |
Why?
|
| Synaptic Transmission | 1 | 2008 | 1175 | 0.010 |
Why?
|
| Vocabulary | 1 | 2002 | 165 | 0.010 |
Why?
|
| Psychotherapy | 1 | 2011 | 1645 | 0.010 |
Why?
|
| Behavior | 1 | 2004 | 535 | 0.010 |
Why?
|
| Academic Medical Centers | 1 | 2011 | 2780 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2007 | 3624 | 0.010 |
Why?
|
| Mental Health Services | 1 | 2011 | 1723 | 0.010 |
Why?
|
| Risk Factors | 1 | 2006 | 74840 | 0.010 |
Why?
|
| Affect | 1 | 2007 | 1500 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2007 | 4108 | 0.010 |
Why?
|
| Urinary Incontinence | 1 | 2002 | 491 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1999 | 20659 | 0.010 |
Why?
|
| Motor Cortex | 1 | 2004 | 1003 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2006 | 3672 | 0.010 |
Why?
|
| Mood Disorders | 1 | 2002 | 1128 | 0.010 |
Why?
|
| Risk | 1 | 2007 | 9591 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2008 | 3819 | 0.010 |
Why?
|
| Neural Pathways | 1 | 2005 | 3085 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2008 | 4424 | 0.010 |
Why?
|
| Prognosis | 1 | 2014 | 29922 | 0.010 |
Why?
|
| Learning | 1 | 2002 | 1755 | 0.010 |
Why?
|
| Models, Biological | 1 | 2008 | 9443 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2002 | 5302 | 0.010 |
Why?
|
| Phenotype | 1 | 2006 | 16721 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 2003 | 15398 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 2002 | 39193 | 0.000 |
Why?
|